每經AI快(kuai)訊，盟(meng)科(ke)(ke)藥(yao)業(ye)（SH 688373，收盤(pan)價(jia)：7.82元）9月9日(ri)晚(wan)間發(fa)布(bu)公(gong)(gong)(gong)(gong)(gong)告稱，截至本公(gong)(gong)(gong)(gong)(gong)告披露日(ri)，上海盟(meng)科(ke)(ke)藥(yao)業(ye)股(gu)(gu)份(fen)(fen)(fen)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)東(dong)Best Idea International Limited持(chi)有(you)(you)(you)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)約(yue)5844萬股(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)總數的(de)8.91%；股(gu)(gu)東(dong)JSR Limited持(chi)有(you)(you)(you)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)約(yue)3084萬股(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)總數的(de)4.7%；股(gu)(gu)東(dong)GP TMT Holdings Limited持(chi)有(you)(you)(you)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)約(yue)1837萬股(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)總數的(de)2.8%。JSR與GP TMT為一致(zhi)行(xing)動(dong)人，二者(zhe)合(he)計持(chi)有(you)(you)(you)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)約(yue)4922萬股(gu)(gu)，占公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)總數7.51%。相關股(gu)(gu)份(fen)(fen)(fen)均為公(gong)(gong)(gong)(gong)(gong)司(si)(si)首次公(gong)(gong)(gong)(gong)(gong)開發(fa)行(xing)并上市(shi)(shi)前取得的(de)股(gu)(gu)份(fen)(fen)(fen)。公(gong)(gong)(gong)(gong)(gong)司(si)(si)于近日(ri)收到Best Idea、JSR及GP TMT出具的(de)《關于股(gu)(gu)東(dong)減(jian)持(chi)計劃的(de)告知函》，股(gu)(gu)東(dong)Best Idea、JSR及GP TMT計劃根據市(shi)(shi)場情況擬通過集中(zhong)競價(jia)交(jiao)易(yi)(yi)和大宗交(jiao)易(yi)(yi)方式減(jian)持(chi)其(qi)所持(chi)有(you)(you)(you)的(de)公(gong)(gong)(gong)(gong)(gong)司(si)(si)股(gu)(gu)份(fen)(fen)(fen)合(he)計不超(chao)過約(yue)3934萬股(gu)(gu)，即(ji)不超(chao)過公(gong)(gong)(gong)(gong)(gong)司(si)(si)總股(gu)(gu)本的(de)6%。

2024年1至12月(yue)份，盟科(ke)藥業(ye)的營業(ye)收入構成為(wei)：醫藥制(zhi)造業(ye)占比100.0%。

截至發稿，盟科藥業市值為(wei)51億元。

每經(jing)頭條（nbdtoutiao）——

（記者 曾健輝）

免(mian)責聲明：本(ben)文內容與(yu)數據僅(jin)供參(can)考，不構(gou)成投資建議，使用(yong)前請核實。據此操作，風險自擔。